Patent · US Active

6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer

US11897867B2 · kind B2 · utility

0Cited by

22References

3Claims

0Family size

Assignees

BAYER HEALTHCARE LLC · DE
Bayer Pharma Aktiengesellschaft · DE
The Broad Institute, Inc. · US

Inventors

Manuel Ellermann · Berlin, DE
Timothy A. Lewis · Marlborough, US

Key dates

Filing date	Aug 2, 2018
Grant date	Feb 13, 2024
Priority date	—
Expiry date	Jul 25, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides 6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives of formula (I): The present invention provides 6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.